Clin2
NCT07044947Possibly a fitNot yet recruiting

Antifungal pill for vaginal yeast infection

Vulvovaginal Candidiasis

Part of Infections, Women’s health & pregnancy clinical trials.

This study tests an antifungal pill called oteseconazole for women with a yeast infection of the vagina. It may offer a simpler treatment option than creams or inserts.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
3,000 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must be a woman aged 18 or older.
  • Your vaginal yeast infection symptoms (like itching, burning, or discharge) need to be moderate to severe, as rated by a doctor.
  • You should not be pregnant or breastfeeding.
  • You cannot be taking part in any other clinical trial right now or plan to in the near future.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06480604Recruiting
Probiotic for yeast infection prevention

This trial tests if taking a multi-strain probiotic daily can prevent repeat yeast infections in women who have had at least three infections in the past year.

Vadodara, Gujarat
NCT05753813Recruiting· Early Phase 1
Study lactic acid gel to change vaginal germs

This early study tests whether placing a lactic acid gel inside the vagina can change the vaginal “microbiome,” the mix of germs, to help reduce repeat BV or yeast infections. You may join if you’ve had at least two recent episodes that needed treatment.

Honolulu, Hawaii
NCT07521137Recruiting· Phase 2
Biweekly occidiofungin for recurring yeast infections

This study tests occidiofungin, a new antifungal medication inserted into the vagina twice a week to prevent recurring yeast infections (vulvovaginal candidiasis). The goal is to see if this treatment can stop yeast infections from coming back.

Birmingham, Alabama
NCT06771063Recruiting· Phase 2
Testing a new pill for vaginal yeast infections

This study tests a new oral medication called WXSH0102 for treating vaginal yeast infections (VVC). It aims to see if the drug is safe and effective for women with active symptoms.

Beijing, Beijing Municipality
NCT07703241Not yet recruiting
Vaginal ovule for bacterial vaginosis or yeast infection

This study tests a vaginal ovule (a small tablet inserted into the vagina) to see if it safely treats two common vaginal infections: bacterial vaginosis and yeast infections (candidiasis). It may help relieve symptoms like discharge, itching, and burning.

Naples
NCT06835361Recruiting· Phase 2/Phase 3
Comparing two yeast infection treatments for women

This trial tests if a new combination vaginal suppository works better than the standard one for women with yeast infections. It aims to see if adding lactulose to clotrimazole helps clear the infection faster or more completely.

Minsk, Minsk City

Hear when a new Vulvovaginal Candidiasis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.